A xeno-free culturing protocol for pluripotent stem cell-derived oligodendrocyte precursor cell production

Regenerative Medicine

Volumn 6, Issue 4, 2011, Pages 449-460

  Sundberg, Maria ^a   Hyysalo, Anu ^a   Skottman, Heli ^a   Shin, Soojung ^b   Vemuri, Mohan ^b   Suuronen, Riitta ^a,c   Narkilahti, Susanna ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b Life Technologies Inc   (United States)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

human embryonic stem cell derived oligodendrocytes; human recombinant growth factors; oligodendrocyte precursor cells; pluripotent stem cells; xeno free

Indexed keywords

A2B5 PROTEIN; ASCORBIC ACID; CD133 ANTIGEN; GENE PRODUCT; GLIAL FIBRILLARY ACIDIC PROTEIN; HERMES ANTIGEN; LAMININ; LIOTHYRONINE; MICROTUBULE ASSOCIATED PROTEIN 2; NESTIN; NG2 PROTEIN; O4 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TRA 1 81; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT CILIARY NEUROTROPHIC FACTOR; RECOMBINANT EPIDERMAL GROWTH FACTOR; RECOMBINANT GROWTH FACTOR; RECOMBINANT SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL POPULATION; CELL SELECTION; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; EMBRYONIC STEM CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEURAL STEM CELL; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; XENO FREE CULTURING PROTOCOL;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CULTURE MEDIA; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; OLIGODENDROGLIA; PLURIPOTENT STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAINING AND LABELING; TRANSCRIPTION FACTORS;

EID: 79960213372     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.36     Document Type: Article

References (25)

1. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 25, 4694-4705 (2005). (Pubitemid 40664118)
2. Hu BY, Du ZW, Li XJ, Ayala M, Zhang SC. Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development 136, 1443-1452 (2009).
3. Izrael M, Zhang P, Kaufman R, et al. Human oligodendrocytes derived from embryonic stem cells: effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol. Cell Neurosci. 34, 310-323 (2007). (Pubitemid 46330036)
4. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49, 385-396 (2005). (Pubitemid 40222916)
5. Kang SM, Cho MS, Seo H, et al. Efficient induction of oligodendrocytes from human embryonic stem cells. Stem Cells 25, 419-424 (2007).
6. Sundberg M, Skottman H, Suuronen R, Narkilahti S. Production and isolation of NG2+ oligodendrocyte precursors from human embryonic stem cells in defined serum-free medium. Stem Cell Res. 5, 91-103 (2010).
7. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998). (Pubitemid 28516247)
8. Ahrlund-Richter L, De Luca M, Marshak DR, Munsie M, Veiga A, Rao M. Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell 4, 20-26 (2009).
9. Skottman H, Narkilahti S, Hovatta O. Challenges and approaches to the culture of pluripotent human embryonic stem cells. Regen. Med. 2, 265-273 (2007). (Pubitemid 46845885)
10. Pruszak J, Ludwig W, Blak A, Alavian K, Isacson O. CD15, CD24 and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells 27, 2928-2940 (2009).
11. Sundberg M, Jansson L, Ketolainen J, et al. CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells. Stem Cell Res. 2, 113-124 (2009).
12. Sundberg M, Andersson P-H, Åkesson E, et al. Markers of pluripotency and differentiation in human neural precursor cells derived from embryonic stem cells and CNS tissue. Cell Transplantation 20, 177-191 (2011).
13. Heiskanen A, Satomaa T, Tiitinen S, et al. N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25, 197-202 (2007). (Pubitemid 46052991)
14. Martin MJ, Muotri A, Gage F, Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11, 228-232 (2005). (Pubitemid 40321360)
15. Skottman H. Derivation and characterization of three new human embryonic stem cell lines in Finland. In Vitro Cell Dev. Biol. Anim. 46, 206-209 (2010).
16. Rajala K, Hakala H, Panula S, et al. Testing of nine different xeno-free culture media for human embryonic stem cell cultures. Hum. Reprod. 22, 1231-1238 (2007). (Pubitemid 47062789)
17. Rajala K, Lindroos B, Hussein SM, et al. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One 5, e10246 (2010).
18. Chen Y, Stevens B, Chang J, Milbrandt J, Barres BA, Hell JW. NS21: re-defined and modified supplement B27 for neuronal cultures. J. Neurosci. Methods 171, 239-247 (2008).
19. Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB. Co-localization of NG2 proteoglycan and PDGF a-receptor on O2A progenitor cells in the developing rat brain. J. Neurosci. Res. 43, 299-314 (1996). (Pubitemid 26054018)
20. Bansal R, Stefansson K, Pfeiffer SE. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J. Neurochem. 58, 2221-2229 (1992).
21. Brederlau A, Correia AS, Anisimov SV, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinsons disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24, 1433-1440 (2006). (Pubitemid 44464659)
22. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA: Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12, 1259-1268 (2006). (Pubitemid 44706928)
23. Schulz TC, Noggle SA, Palmarini GM, et al. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 22, 1218-1238 (2004). (Pubitemid 39636400)
24. Sonntag KC, Pruszak J, Yoshizaki T, et al. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the BMP antagonist Noggin. Stem Cells 25, 411-418 (2007). (Pubitemid 46232796)
25. European Human Embryonic Stem Cell Registry www.hescreg.eu